Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials

Benzer Materyaller

• The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
  Yazar:: Smith, Jaclyn A., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
  Yazar:: Morice, Alyn H., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Treating acute cough: wet versus dry – have we got the paradigm wrong?
  Yazar:: Morice, Alyn H., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
  Yazar:: Muccino, David R., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Ascertainment of cause‐specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
  Yazar:: McGarvey, Lorcan P, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)